Back
ESC Premium Access

From clinical evidence to patient management- How to reverse DOAC in clinical practice .

Session: Paradigm shift in DOAC reversal - What are the current therapeutic options?
Topic: Pharmacology and Pharmacotherapy, Other
Speaker: Professor S. Middeldorp (Amsterdam, NL)
Sponsored by Portola Pharmaceutials Inc.
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Professor Saskia Middeldorp

Amsterdam UMC - Location VUmc, Amsterdam (Netherlands (The))
3 presentations
0 follower

4 more presentations in this session

Introduction and welcome

Speaker: Associate Professor E. Grove (Aarhus, DK)

Access
Like
Thumbnail

DOAC-related bleeding: demographics, risk factors & guidelines .

Speaker: Professor J. Oldgren (Uppsala, SE)

Access
Like
Thumbnail

Specific reversal agent for FXa - Inhibitor treatment - What the study data reveals? .

Speaker: Doctor A. Cohen (London, GB)

Access
Like
Thumbnail

Plenary questions and discussion

Speaker: Professor E. Lindhoff-Last (DE) Associate Professor E. Grove (Aarhus, DK)

Access
Like
Thumbnail

Access the full session

Paradigm shift in DOAC reversal - What are the current therapeutic options?

Speakers: Professor S. Middeldorp, Associate Professor E. Grove, Professor J. Oldgren, Doctor A. Cohen, Professor E. Lindhoff-Last...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources